Can we determine unique clinical trajectories in our myositis cohort using validated outcome measures for skin, lung, and muscle?
Increase efficiency of healthcare delivery and use our multidisciplinary approach, trajectory analysis, and novel subgroup identification to tailor the monitoring and treatment of the disease to the individual.
Leverage the longitudinal nature of our clinical cohort, coupled with prospectively collected biospecimens, to better classify unique phenotypes of inflammatory muscle disease. Precise phenotyping allows for a directed personalized approach to potentially better identify early signs of disease flare, determine appropriate clinical trial candidates that represent a more homogenous group, and eliminate the longstanding trial and error approach of therapeutic decision making.
Questions we're asking that inform us on how to best care for patients include:
Identify Distinct Patient Trajectories
Can we determine clinical and biologic predictors of response to different treatment regimens?
Can we tailor cancer screening recommendations to distinct subgroups of myositis patients?
Patient Care for Myositis
The Johns Hopkins Myositis Center brings together a wide range of expertise and takes a true multi-disciplinary approach to care. Our program couples clinical and basic science research in the departments of Rheumatology and Neurology at the Johns Hopkins Bayview campus and incorporates Pulmonology, Physical Medicine and Rehabilitation, including Occupational and Speech therapy. Find out more about the appointment process.